Navigation Links
PharMEDium Elects William R. Spalding to Board of Directors
Date:8/25/2010

LAKE FOREST, Ill., Aug. 25 /PRNewswire/ -- David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation announced the election of William R. Spalding to the company's Board of Directors.

Spalding is Co-founder and Principal of The Crawford Spalding Group, an advisory and management services firm that applies extensive operational, financial and transactional expertise to assist companies primarily in the healthcare services industry.  Jonas stated, "Bill's experience in the healthcare services industry and his expertise with respect to matters of strategy, corporate development, operations and governmental affairs equip him well to add value to PharMEDium as a member of our Board of Directors going forward.  He will be an asset."

Mr. Spalding's career experience includes EVP Strategy and Managed Care for CVSCaremark Inc., a Fortune 20 company, and Senior Partner in the Atlanta office of King & Spalding LLP, where he led the Private Equity & Investment Funds Practice and was a member of the firm's management committee.

PharMEDium is the national leading provider of pharmacy sterile intravenous admixture compounding services. The PharMEDium network of state licensed and federally registered compounding centers provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and FDA regulations, including USP Chapter <797>, and DEA requirements.  For more information on PharMEDium, visit www.pharmedium.com.


'/>"/>
SOURCE PharMEDium
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
2. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
3. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
4. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
5. Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions
6. Sarah Cannon Research Institute Selects OmniComm Systems Electronic Data Capture Solution, TrialMaster(TM), for Clinical Trials Management
7. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
8. University of California Los Angeles Selects Velos eResearch
9. Spherix Elects New Independent Director, and Elects Chairman of the Board
10. Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
11. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2017)... SAN DIEGO , May 4, 2017  The ... Clinical and Scientific Meeting— OBP Medical , a leading ... announced the launch of a new extra-small size and ... ER-SPEC vaginal specula. Already available in small, ... sizes makes OBP Medical,s line of single-use lighted specula ...
(Date:5/4/2017)...   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and ... announced that the Company,s first quarter 2017 financial results ... 11, 2017, and that the Company will host a ... that afternoon. Management will provide an overview of the ...
(Date:5/3/2017)... May 3, 2017  Getinge, a leading global ... quality enhancement and cost efficiency within healthcare and ... of contemporary practice demonstrating that intra-aortic balloon counterpulsation ... critically ill patients. The single-center, retrospective, observational study ... volume MEGA ® 50cc intra-aortic balloon (IAB) ...
Breaking Medicine Technology:
(Date:5/27/2017)... ... May 26, 2017 , ... A May 8 article on CBCNews ... or respiratory issues that are not responsive to antibiotics nevertheless obtain prescriptions for them. ... largely responsible for the problem both in Canada and the United States. Dr. Michael ...
(Date:5/27/2017)... NY (PRWEB) , ... May 27, 2017 , ... From ... and Oticon. The three-day event was held at the Marriott Syracuse Downtown Hotel ... with the hearing brand and network of independent hearing healthcare providers to help them ...
(Date:5/26/2017)... NY (PRWEB) , ... May 26, 2017 , ... ... (SAB) met this week to review more than eighty-nine grant submissions all ... and emerging young scientists in the Parkinson’s field.     , The American Parkinson Disease ...
(Date:5/26/2017)... ... May 26, 2017 , ... Amir Qureshi, MD is the ... versatile, patient-centric spinal cord stimulation system. The Nuvectra™ Algovita SCS System has been FDA ... to be the first in Arkansas to introduce the most powerful SCS system and ...
(Date:5/26/2017)... ... May 26, 2017 , ... Boar’s Head Brand®, one ... for Memorial Day entertaining that are sure to satisfy your guests’ flavor cravings, ... meats and cheeses featured in these refreshingly balanced recipes are packed with flavor, ...
Breaking Medicine News(10 mins):